P. Andre, F. Komurian-pradel, S. Deforges, M. Perret, J. Berland et al., Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles, Journal of Virology, vol.76, issue.14, pp.6919-6928, 2002.
DOI : 10.1128/JVI.76.14.6919-6928.2002

H. Aizaki, K. Morikawa, M. Fukasawa, H. Hara, Y. Inoue et al., Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection, Journal of Virology, vol.82, issue.12, pp.5715-5724, 2008.
DOI : 10.1128/JVI.02530-07

M. Zeisel, I. Fofana, S. Fafi-kremer, and T. Baumert, Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies, Journal of Hepatology, vol.54, issue.3, pp.566-576, 2011.
DOI : 10.1016/j.jhep.2010.10.014

URL : https://hal.archives-ouvertes.fr/inserm-00701487

S. Haid, T. Pietschmann, and E. Pecheur, Low pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus Particles, Journal of Biological Chemistry, vol.284, issue.26
DOI : 10.1074/jbc.M109.014647

S. Kapadia, H. Barth, T. Baumert, J. Mckeating, and F. Chisari, Initiation of Hepatitis C Virus Infection Is Dependent on Cholesterol and Cooperativity between CD81 and Scavenger Receptor B Type I, Journal of Virology, vol.81, issue.1, pp.374-383, 2007.
DOI : 10.1128/JVI.01134-06

R. Bartenschlager, F. Penin, V. Lohmann, and P. Andre, Assembly of infectious hepatitis C virus particles, Trends in Microbiology, vol.19, issue.2, pp.95-103, 2011.
DOI : 10.1016/j.tim.2010.11.005

B. Sainz, J. Barretto, N. Martin, D. Hiraga, N. Imamura et al., Identification of the Niemann-Pick C1???like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor, Nature Medicine, vol.18, issue.2, 2012.
DOI : 10.1016/S0002-9440(10)63352-4

L. Jia, J. Betters, and L. Yu, Niemann-Pick C1-Like 1 (NPC1L1) Protein in Intestinal and Hepatic Cholesterol Transport, Annual Review of Physiology, vol.73, issue.1, pp.239-259, 2011.
DOI : 10.1146/annurev-physiol-012110-142233

S. Harrison, L. Rossaro, K. Hu, K. Patel, H. Tillmann et al., Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy, Hepatology, vol.27, issue.3, pp.864-874, 2010.
DOI : 10.1002/hep.23787

M. Florentin, E. Liberopoulos, and M. Elisaf, Ezetimibe-associated adverse effects: what the clinician needs to know, International Journal of Clinical Practice, vol.84, issue.Suppl. A, pp.88-96, 2008.
DOI : 10.1111/j.1742-1241.2007.01592.x